Holen Sie sich die Stockscreener-App
17.20
0.12%
-0.02
Handel nachbörslich:
17.18
-0.02
-0.12%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt KVUE?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$17.22
Offen:
$17.33
24-Stunden-Volumen:
13.89M
Relative Volume:
0.66
Marktkapitalisierung:
$33.04B
Einnahmen:
$15.29B
Nettoeinkommen (Verlust:
$1.62B
KGV:
20.40
EPS:
0.8433
Netto-Cashflow:
$1.82B
1W Leistung:
-3.37%
1M Leistung:
-10.09%
6M Leistung:
+0.35%
1J Leistung:
+9.35%
1-Tages-Spanne:
$17.16
$17.38
1-Wochen-Bereich:
$17.16
$18.08
52-Wochen-Spanne:
$14.02
$20.13
Kenvue Inc Stock (KVUE) Company Profile
Firmenname
Kenvue Inc
Sektor
Telefon
908-874-1200
Adresse
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, CCL, EL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
17.20 | 34.19B | 15.29B | 1.62B | 1.82B | 0.8433 |
PG
Procter Gamble Co
|
144.91 | 334.35B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
59.70 | 128.57B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
84.26 | 68.60B | 20.80B | 2.22B | 3.77B | 2.5772 |
CCL
Colgate Palmolive Co
|
25.76 | 30.47B | 26.98B | 3.10B | 2.98B | 2.2492 |
EL
Estee Lauder Cos Inc
|
91.97 | 34.18B | 14.85B | -248.00M | 1.29B | -0.6966 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Herabstufung | Jefferies | Buy → Hold |
| 2025-10-29 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2025-09-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2025-04-10 | Eingeleitet | Redburn Atlantic | Neutral |
| 2025-03-24 | Eingeleitet | Evercore ISI | In-line |
| 2025-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-09-24 | Eingeleitet | Jefferies | Buy |
| 2024-09-24 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-05-28 | Fortgesetzt | Citigroup | Neutral |
| 2024-04-11 | Eingeleitet | Bernstein | Underperform |
| 2024-04-03 | Eingeleitet | William Blair | Mkt Perform |
| 2024-03-01 | Fortgesetzt | Goldman | Neutral |
| 2023-11-17 | Eingeleitet | Piper Sandler | Neutral |
| 2023-09-11 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-09-07 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-09-06 | Eingeleitet | Argus | Hold |
| 2023-08-24 | Hochstufung | Goldman | Neutral → Buy |
| 2023-07-25 | Eingeleitet | Edward Jones | Buy |
| 2023-06-01 | Eingeleitet | HSBC Securities | Hold |
| 2023-05-30 | Eingeleitet | BofA Securities | Buy |
| 2023-05-30 | Eingeleitet | Citigroup | Neutral |
| 2023-05-30 | Eingeleitet | Deutsche Bank | Hold |
| 2023-05-30 | Eingeleitet | Exane BNP Paribas | Neutral |
| 2023-05-30 | Eingeleitet | Goldman | Neutral |
| 2023-05-30 | Eingeleitet | JP Morgan | Overweight |
| 2023-05-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-05-30 | Eingeleitet | UBS | Neutral |
Alle ansehen
Kenvue Inc Aktie (KVUE) Neueste Nachrichten
Montgomery Township Weighs Farmland Preservation, Public Health, and Kenvue Site Redevelopment - themontynews.org
Keurig taps Kimberly-Clark exec to lead coffee spinoff - The Business Journals
Kimberly-Clark Slides as Investors Weigh Leadership Change and Kenvue Deal Execution - Quiver Quantitative
Kimberly-Clark Reshapes Leadership Ahead of Kenvue Acquisition - citybiz
Kimberly-Clark announces executive changes ahead of Kenvue deal - Investing.com
Kimberly-Clark President, COO Russ Torres to Step Down Ahead of Kenvue Acquisition - marketscreener.com
Kimberly-Clark's COO will leave for an outside CEO role - Stock Titan
Kimberly-Clark Announces Planned Executive Transitions and Updates to Post-Closing Leadership Team - PR Newswire
Worldwide oral disease cases reach 3.73 billion. Listerine is launching a prevention campaign. - Stock Titan
Kenvue Inc. stock falls Wednesday, underperforms market - MarketWatch
Kenvue brands present skin and hair research at Vienna congress - Investing.com
Kenvue brands present skin and hair research at EADV congress - StreetInsider
Kenvue: Neutrogena, Aveeno, and Regaine Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair - FinanzNachrichten.de
Form 4 Kenvue Inc For: 29 September By Investing.com - Investing.com Canada
Deferred director pay adds 1,300 stock units for Jeffrey C. Smith at Kenvue (KVUE). - Stock Titan
Kenvue | 4: Statement of changes in beneficial ownership of securities-Director ALLISON RICHARD E JR - Moomoo
1,461 shares withheld for taxes on a Kenvue (KVUE) executive’s stock awards - Stock Titan
Kenvue (KVUE) director Richard E. Allison Jr. receives deferred pay in shares - Stock Titan
Kimberly-Clark Pays Out Almost Everything It Earns. Can the Dividend Survive the Kenvue Deal? - Yahoo Finance
Kimberly-Clark (KMB) Launches $7 Billion Exchange Offer for Kenv - GuruFocus
Kimberly-Clark launches $7B note exchange offer linked to Kenvue acquisition - Pluang
Kimberly-Clark Corporation (KMB) Starts Exchange Offers for Up to $7.0B Kenvue Notes - TradingView
Kenvue stock at USD 17.80 on September 25, 2026 - AD HOC NEWS
Kenvue Inc. stock rises Friday, outperforms market - MarketWatch
The Technical Signals Behind (KVUE) That Institutions Follow - Stock Traders Daily
Kenvue stock slips 1.06 percent ahead of the open - AD HOC NEWS
Kenvue stock trades 11.9 percent below its yearly high - AD HOC NEWS
Andra AP fonden Acquires Shares of 210,900 Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark offers remedies in bid for EU approval of Kenvue deal - reuters.com
EU extends review of Kimberly-Clark’s $40B Kenvue deal - TradingView
kimberly clark offers eu remedies for 40 billion kenvue deal - grafa.com
Kenvue stock rises as Kimberly Clark advances its takeover bid - AD HOC NEWS
Kimberly-Clark Offers Concessions for EU Approval of $40 Billion Kenvue Deal - marketscreener.com
Nykredit A S Acquires Shares of 235,332 Kenvue Inc. $KVUE - MarketBeat
Kenvue stock adds 1.1 percent ahead of the open - AD HOC NEWS
Kenvue Inc. (KVUE) Edges Higher as Shares Test Mid-Range ResistanceDaily Profile - siam.in
Kenvue Inc. stock rises Tuesday, outperforms market - MarketWatch
Kenvue stock gains 0.40 percent as dividend trading begins - AD HOC NEWS
Kenvue stock heads into the open after a 0.40% gain. - AD HOC NEWS
Kenvue stock trades ex-dividend as income focus grows - AD HOC NEWS
Kenvue’s Climate Transition Plan: Goals, Progress, and Strategy - CSRwire
Kenvue Inc's Dividend Analysis - Yahoo Finance
Kenvue stock heads into the open ex-dividend after a modest gain - AD HOC NEWS
Kenvue stock edges higher as quarterly earnings beat expectations - AD HOC NEWS
Engineers Gate Manager LP Reduces Stock Position in Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark Corporation - Britannica
Kenvue stock holds near deal-implied value as Kimberly-Clark acquisition advances - AD HOC NEWS
Former J&J Unit Beats Claims Its Sunscreen Caused Cancer - law360.com
Canaccord Genuity Keeps Their Buy Rating on Kenvue, Inc. (KVUE) - The Globe and Mail
Kenvue Inc. $KVUE Shares Sold by Corient Private Wealth LP - marketbeat.com
Better Dividend King to Buy and Hold: Johnson & Johnson or Kenvue? - Yahoo Finance
Finanzdaten der Kenvue Inc-Aktie (KVUE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):